drugset / Trial / NCT00540956

Natural Killer Cells in Older Patients With Acute Myeloid Leukemia

NCT00540956

Completed 40 enrolled Institut Paoli-Calmettes
Open-labelTreatment

Summary

RATIONALE: Studying natural killer cells in samples of blood from patients with cancer may help doctors find out how these cells are effected by chemotherapy. PURPOSE: This clinical trial is studying natural killer cells in older patients with acute myeloid leukemia.

Timeline

Start
2006-11
Primary completion
2011-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Cytarabine Small molecule

Indications